Tune Therapeutics
Healthcare & Life Sciences
Recent Finacing
Series B
Recent Raise
$175M
Tune Therapeutics is a company specializing in epigenome editing to develop therapies for chronic diseases, including a clinical-stage drug for chronic Hepatitis B.
Focus Areas
Epigenome editing
gene repression
epigenetic silencing
chronic Hepatitis B
gene therapy
cell therapy
Investors
